Simplifying the process for identifying drug combinations by drug recognition experts.
OBJECTIVE
The purpose of this study is to statistically identify the set of drug-related cues from Drug Evaluation and Classification (DEC) evaluations that significantly predict the categories of drugs used by suspected drug-impaired drivers.


METHODS
Data from 819 completed Canadian DEC evaluations of combinations of central nervous system (CNS) stimulants with cannabis, CNS stimulants with narcotic analgesics, cannabis with alcohol, and no-drug cases were analyzed using a multinomial logistic regression procedure.


RESULTS
Eleven clinical indicators from the DEC evaluations significantly enhanced the prediction of drugs used by suspected drug-impaired drivers, including condition of the eyes, lack of convergence, rebound dilation, reaction to light, mean pulse rate, presence of visible injection sites, performance on the Horizontal Gaze Nystagmus Test, pupil size in darkness, performance on the One-Leg Stand Test, muscle tone, and performance on the Walk-and-Turn Test.


CONCLUSIONS
The findings from this study will facilitate the process of identifying the correct categories of drugs ingested by suspected drug-impaired drivers by focusing on critical signs and symptoms of drug influence. This work will have direct and immediate relevance to the training of drug recognition experts (DREs) by providing the foundation for an innovative, statistically based approach to drug classification decisions by DREs. This research will also facilitate the enforcement of drug-impaired driving laws in Canada to help make Canadian roadways safer for all.
Porath-Waller
Amy J
AJ
Canadian Centre on Substance Abuse, Ottawa, Ontario, Canada. aporath-waller@ccsa.ca
Beirness
Douglas J
DJ
D000704:Analysis of Variance; D001334:Automobile Driving / Q000331:legislation & jurisprudence*; D002170:Canada; D002188:Cannabis; D000697:Central Nervous System Stimulants; D004338:Drug Combinations; D000431:Ethanol; D006801:Humans; D016015:Logistic Models; D009294:Narcotics; D011237:Predictive Value of Tests; D015813:Substance Abuse Detection / Q000379:methods* / Q000706:statistics & numerical data; D019966:Substance-Related Disorders / Q000175:diagnosis
D000697:Central Nervous System Stimulants; D004338:Drug Combinations; D009294:Narcotics; D000431:Ethanol